Evidence map›Paper›PMID 40142797›Full record

ArticleJournal of clinical medicine2025

A New Histology-Based Prognostic Index for Acute Myeloid Leukemia: Preliminary Results for the "AML Urayasu Classification".

Toru Mitsumori, Hideaki Nitta, Haruko Takizawa, Hiroko Iizuka-Honma, Chiho Furuya, Maki Fujishiro, Shigeki Tomita, Akane Hashizume, Tomohiro Sawada, Kazunori Miyake and 4 more

Abstract readCase Reports
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Toru MitsumoriDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Japan.
Hideaki NittaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Japan.ORCID 0000-0002-1209-6594
Haruko TakizawaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Japan.
Hiroko Iizuka-HonmaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Japan.ORCID 0000-0002-7684-2728
Chiho FuruyaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Japan.ORCID 0009-0000-6630-6684
Maki FujishiroInstitute for Environmental and Gender-Specific Medicine, Juntendo University Urayasu Hospital, Urayasu 279-0021, Japan.
Shigeki TomitaDepartment of Diagnostic Pathology, Juntendo University Urayasu Hospital, Urayasu 279-0021, Japan.ORCID 0000-0001-7212-2769
Akane HashizumeDepartment of Diagnostic Pathology, Juntendo University Urayasu Hospital, Urayasu 279-0021, Japan.ORCID 0000-0003-1493-2354
Tomohiro SawadaDepartment of Clinical Laboratory, Juntendo University Urayasu Hospital, Urayasu 279-0021, Japan.ORCID 0000-0003-3159-8706
Kazunori MiyakeDepartment of Clinical Laboratory, Faculty of Medical Sciences, Juntendo University, Tokyo 113-8421, Japan.
Mitsuo OkuboLaboratory of Blood Transfusion, Juntendo University Urayasu Hospital, Urayasu 279-0021, Japan.ORCID 0000-0001-9098-4477
Yasunobu SekiguchiHematology Clinic, Saitama Cancer Center, Saitama 362-0806, Japan.
Miki AndoDivision of Hematology, Juntendo University Juntendo Hospital, Tokyo 113-0033, Japan.ORCID 0000-0001-8871-1330
Masaaki NoguchiDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Japan.ORCID 0000-0001-9458-2707

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AKR1B1AKR1B10AMLMRP1P53prognostic indexUrayasu classification

Identifiers

PMID40142797
PMCPMC11943192

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.